Clinical Trial Update: Arimidex Observational: Reason for and Effect of Change From Tamoxifen

View source ↗

Summary

An observational update on Arimidex (anastrozole) examines why patients were switched from Tamoxifen and the effects of that change in breast cancer. The trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Status: COMPLETED